We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

151 hedge funds and large institutions have $299M invested in Definium Therapeutics in 2024 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 39 increasing their positions, 24 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

282% more call options, than puts

Call options by funds: $14.4M | Put options by funds: $3.77M

63% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 27

63% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 24

12% more funds holding

Funds holding: 135 → 151 (+16)

9% less capital invested

Capital invested by funds: $327M → $299M (-$28.2M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

26.45% less ownership

Funds ownership: 84.24% → 57.79% (-26%)

Holders
151
Holders Change
+16
Holders Change %
+11.85%
% of All Funds
2.18%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
44
Increased
39
Reduced
24
Closed
27
Calls
$14.4M
Puts
$3.77M
Net Calls
+$10.6M
Net Calls Change
-$11.6M

Top Buyers

1
BlackRock
BlackRock
New York
+$40.1M
2
State Street
State Street
Massachusetts
+$14.7M
3
CC
Commodore Capital
New York
+$11.5M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$10.3M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$9.84M

Top Sellers

1
GPP
Great Point Partners
Connecticut
-$18.8M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$8.11M
3
SCM
Soleus Capital Management
Connecticut
-$7.05M
4
DTC
Deep Track Capital
Connecticut
-$4.92M
5
Millennium Management
Millennium Management
New York
-$3.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of Montreal
51
Bank of Montreal
Ontario, Canada
$240K +$290K +33,133 New
Man Group
52
Man Group
United Kingdom
$231K -$701K -80,115 -71%
CC
53
Caxton Corporation
New Jersey
$219K +$11.5K +1,318 +5%
New York State Common Retirement Fund
54
New York State Common Retirement Fund
New York
$210K +$255K +29,100 New
Janus Henderson Group
55
Janus Henderson Group
United Kingdom
$202K -$8.11M -927,678 -97%
GS
56
GTS Securities
New York
$200K +$25K +2,864 +11%
Manulife (Manufacturers Life Insurance)
57
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$197K +$239K +27,344 New
Voloridge Investment Management
58
Voloridge Investment Management
Florida
$194K +$235K +26,847 New
Citigroup
59
Citigroup
New York
$187K -$745K -85,161 -77%
PI
60
PEAK6 Investments
Illinois
$185K +$89.6K +10,246 +66%
Wells Fargo
61
Wells Fargo
California
$183K +$199K +22,787 +882%
Commonwealth Equity Services
62
Commonwealth Equity Services
Massachusetts
$180K +$997 +114 +0.5%
VOYA Investment Management
63
VOYA Investment Management
Georgia
$175K +$212K +24,208 New
RG
64
Rathbones Group
United Kingdom
$174K – – –
B
65
Bailard
California
$174K – – –
PA
66
Profund Advisors
Maryland
$150K +$182K +20,846 New
MMPW
67
Mitchell McLeod Pugh & Williams
Alabama
$144K – – –
Walleye Capital
68
Walleye Capital
New York
$133K +$162K +18,487 New
Zurich Cantonal Bank
69
Zurich Cantonal Bank
Switzerland
$131K +$159K +18,147 New
Balyasny Asset Management
70
Balyasny Asset Management
Illinois
$127K +$154K +17,663 New
Citadel Advisors
71
Citadel Advisors
Florida
$127K -$348K -39,740 -69%
Rafferty Asset Management
72
Rafferty Asset Management
New York
$125K +$151K +17,299 New
Wolverine Trading
73
Wolverine Trading
Illinois
$125K -$210K -24,022 -58%
FDCDDQ
74
Federation des caisses Desjardins du Quebec
Quebec, Canada
$124K +$27.1K +3,095 +22%
CW
75
CreativeOne Wealth
Kansas
$121K +$147K +16,844 New
1 2
3
4 5

DFTX Hedge Fund Activity: Q2 2024 in Review

151 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q2 2024, worth a combined $299M — down 8.6% from $327M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new DFTX positions and 27 closed out — a net gain of 17 holders — while 39 added to existing stakes and 24 trimmed.

The largest buyer was BlackRock, adding an estimated $40.1M. The largest seller was Great Point Partners, exiting entirely with an estimated $18.8M sold.

  • 151 institutional investors held Definium Therapeutics (DFTX) as of Q2 2024, up from 135 in Q1 2024.
  • Funds reported $299M of Definium Therapeutics stock for Q2 2024, down 8.6% quarter-over-quarter.
  • 44 funds opened new Definium Therapeutics positions in Q2 2024 and 27 closed out, a net change of +17 holders.
  • The largest Definium Therapeutics buyer in Q2 2024 was BlackRock, an estimated $40.1M added.
  • The largest Definium Therapeutics seller in Q2 2024 was Great Point Partners, an estimated $18.8M sold.

Based on aggregated 13F filings for Q2 2024.